Search Results - "Morneau, Kathleen"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Clinical utility of methicillin-resistant Staphylococcus aureus nasal PCR to streamline antimicrobial use in treatment of diabetic foot infection with or without osteomyelitis by Harb, Gaielle, Hopkins, Teri, Yang, Linda, Morneau, Kathleen, Cadena-Zuluaga, Jose, Walter, Elizabeth, Frei, Christopher

    Published in BMC infectious diseases (05-05-2023)
    “…Diabetic Foot Infection (DFI) guidelines recommend empiric methicillin-resistant Staphylococcus aureus (MRSA)-targeted therapy in settings where there is high…”
    Get full text
    Journal Article
  2. 2

    Clinical impact of implementation of rapid diagnostic testing of blood cultures with Staphylococcus aureus on patient outcomes by Gritte, Anndee S., Morneau, Kathleen M., Frei, Christopher R., Cadena-Zuluaga, Jose A., Walter, Elizabeth A., Hopkins, Teri L.

    “…Rapid diagnostic testing in microbiology labs shortens the time to identification of bacteria in blood cultures. Cepheid® GeneXpert® MRSA/SA PCR can be used to…”
    Get full text
    Journal Article
  3. 3

    Correlation Between Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Colonization and MRSA Diabetic Foot Infections by Brondo, Jacquelyn, Morneau, Kathleen, Hopkins, Teri, Yang, Linda, Cadena-Zuluaga, Jose, Walter, Elizabeth

    “…Infectious Diseases Society of America diabetic foot infection (DFI) guidelines indicate empiric methicillin-resistant Staphylococcus aureus (MRSA) coverage…”
    Get full text
    Journal Article
  4. 4

    Antiplatelet Management for Coronary Heart Disease: Advances and Challenges by Gillette, Michael, Morneau, Kathleen, Hoang, Vu, Virani, Salim, Jneid, Hani

    Published in Current atherosclerosis reports (01-06-2016)
    “…Coronary heart disease (CHD) remains the leading cause of death in the USA. CHD accounts for 48 % of all cardiovascular mortality or approximately one of every…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Immunologic resilience and COVID-19 survival advantage by Restrepo, Marcos I., Manoharan, Muthu Saravanan, Sanchez-Reilly, Sandra, Ehsan, Aamir, Branum, Anne P., Winter, Caitlyn, Winter, Lauryn, Pandranki, Lavanya, Carrillo, Andrew, Perez, Graciela L., Anzueto, Antonio, Lee, Monica, Martinez-Vargas, Celida, Sehgal, Raj T., Walter, Elizabeth A., Oakman, Kimberly, Benavides, Raymond, Pugh, Jacqueline A., Abdalla, Mohamed I., Adams, Sandra G., Agnew, Joseph, Barker, Jennifer, Birdwell, Angela, Bradford, Stephen, Briggs, Heather, Marin Corral, Judith, Dacus, Jennifer J., Danaher, Patrick J., DePaul, Scott A., Dickerson, Jill, Elbel, Samantha, Escamilla, Corina, Farrar, Robert, Feldman, David, Flynn, Julianne, Ford, Delvina, Galley, Samantha, Garza, Maritza, Gilman, Sherraine, Gomez, Jennifer, Grassmuck, Sally, Hanson, Joshua, Hastings, Gabrielyd, Haywood, Audrey, Hinojosa, Cecilia, Ho, Tony T., Jewell, Pamela, Lester, Chadwick S., Levine, Stephanie M., Louder, Angel, Maldonado, Rachel, McElligott, Neil, Medlin, Laura, Mireles, Myra, Morneau, Kathleen, Nambiar, Anoop, Nathanson, Robert, Pascual-Guardia, Sergi, Patterson, Marisa, Perez, Rogelio, Phillips, Robert E., Polk, Patrick B., Pomager, Michael A., Preston, Kristy J., Rangel, Michelle, Reichelderfer, Renee L., Renz, Evan M., Ross, Jeanette, Rudd, Teresa, Sanchez, Maria E., Sanders, Tammy, Schindler, Kevin C., Schmit, David, Solorzano, Claudio, Soni, Nilam, Tam, Win S., Tovar, Edward J., Tyler, Anna R., Veloso, Maria C., Venticinque, Steven G., Villalpando, Jorge A., Villanueva, Melissa, Villegas, Lauren, Wallace, Andrew, Wang, Emily, Williamson, Andreia, Trammell Velasquez, Sadie A., Yunes, Andrea, Letendre, Scott, Steri, Maristella, Orrù, Valeria, Fiorillo, Edoardo, Cucca, Francesco, Moreira, Alvaro G., Zhang, Nu, Agan, Brian K., He, Weijing, Clark, Robert A., Okulicz, Jason F., Ahuja, Sunil K.

    Published in Journal of allergy and clinical immunology (01-11-2021)
    “…The risk of severe coronavirus disease 2019 (COVID-19) varies significantly among persons of similar age and is higher in males. Age-independent, sex-biased…”
    Get full text
    Journal Article
  8. 8

    890. Bundled Antimicrobial Stewardship Intervention Reduces Inpatient Third Generation Cephalosporin Use without Restriction by Hopkins, Teri L, Yang, Linda, Douglass, Dana, Sanchez, Chelsea, Morneau, Kathleen, Cadena-Zuluaga, Jose, Walter, Elizabeth

    Published in Open forum infectious diseases (15-12-2022)
    “…Abstract Background The use of third generation cephalosporins (3GC) has been linked to collateral damage such as increased risk of infection with C…”
    Get full text
    Journal Article
  9. 9

    Timing to antibiotic therapy in septic oncologic patients presenting without hypotension by Morneau, Kathleen, Chisholm, Gary B., Tverdek, Frank, Bruno, Jeffrey, Toale, Katy M.

    Published in Supportive care in cancer (01-11-2017)
    “…Purpose Sepsis accounts for only 2% of the hospitalizations worldwide but more than 17% of total in-hospital mortality. Inappropriate antimicrobial selection…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel by Morneau, Kathleen M, Reaves, Anne B, Martin, Julie B, Oliphant, Carrie S

    Published in Journal of managed care pharmacy (01-02-2014)
    “…Dual antiplatelet therapy (DAPT) has been found to reduce the risk of cardiac death, myocardial infarction, stroke, and stent thrombosis following acute…”
    Get full text
    Journal Article
  12. 12

    2133. Clinical Impact of Implementation of Rapid Diagnostic Testing of Blood Cultures on Patient Outcomes by Gritte, Anndee, Hopkins, Teri, Morneau, Kathleen, Frei, Christopher R, Cadena-Zuluaga, Jose, Walter, Elizabeth

    Published in Open forum infectious diseases (23-10-2019)
    “…Abstract Background Rapid diagnostic testing (RDT) in microbiology labs shortens the time to identification of bacteria in blood cultures. This study evaluates…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Enoxaparin vs Continuous Heparin for Periprocedural Bridging in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease by Schexnayder, Chandler David, Aguilar, Christine, Morneau, Kathleen

    Published in Federal practitioner (01-07-2019)
    “…Bridging with enoxaparin rather than heparin has the potential to reduce the length of hospital stay, incidence of nosocomial infections, and cost of…”
    Get full text
    Journal Article